Susan G. Komen is the world's largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Since its founding in 1982, Komen has funded more than $889 million in research and provided $1.95 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide. Komen was founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life.

Susan G. Komen Bahamas
Race for the Cure

The Impact of Genetic Research on Breast Cancer in The Bahamas: Dr. John Lunn
Generic research has shown that Bahamian women with breast cancer have the highest prevalence of an inherited gene in the BRAC gene in the world. In fact, more than 25% of Bahamian women with breast cancer have this inherited pre-disposition. Carriers of this mutation can now plan preventative strategies. More and more young women are now coming forward for prophylactic bilateral mastectomy and reconstruction. They are also aware that if they have their ovaries removed (at age 35) it will give them a 70% protection against breast cancer and eliminate the risk of ovarian cancer which is also associated with this generic abnormality.
Research is now attempting to establish the frequency of this abnormal gene in the unaffected population, so that rational scientific preventative strategies can be planned for the whole population.
Government is being diligent in creating policies that ensure the health of the country's most vulnerable citizens.
Women who have the mutation have up to an 85% chance of developing breast cancer.
Bahamian women have three different genes of breast cancer.